Human clinical trials could begin as early as next year
A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models. They published their findings in the journal Translational Stroke Research.
The research team led by UGA professor Steven Stice and Nasrul Hoda of Augusta University created a treatment called AB126 using extracellular vesicles (EV), fluid-filled structures known as exosomes, which are generated from human neural stem cells.
Fully able to cloak itself within the bloodstream, this type of regenerative EV therapy appears to be the most promising in overcoming the limitations of many cell therapies—with the ability for exosomes to carry and deliver multiple doses—as well as the ability to store and administer treatment. Small in size, the tiny tubular shape of an exosome allows EV therapy to cross barriers that cells cannot.
“This is truly exciting evidence, because exosomes provide a stealth-like characteristic, invisible even to the body’s own defenses,” said Stice, Georgia Research Alliance Eminent Scholar and D.W. Brooks Distinguished Professor in the College of Agricultural and Environmental Sciences. “When packaged with therapeutics, these treatments can actually change cell progression and improve functional recovery.”
Following the administration of AB126, the researchers used MRI scans to measure brain atrophy rates in preclinical, age-matched stroke models, which showed an approximately 35 percent decrease in the size of injury and 50 percent reduction in brain tissue loss—something not observed acutely in previous studies of exosome treatment for stroke.
Outside of rodents, the results were replicated by Franklin West, associate professor of animal and dairy science, and fellow RBC members using a porcine model of stroke—the only one of its kind in the U.S.
Based on these pre-clinical results, ArunA Biomedical plans to begin human studies in 2019, said Stice, who is also chief scientific officer of ArunA Biomedical.
“Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function,” said Stice. “Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models.”
Named as part of the ‘stroke belt’ region, Georgia continues to exceed the national average in stroke deaths, which is the third leading cause of death in the U.S., with more than 140,000 Americans dying each year, according to the Centers for Disease Control and Prevention.
ArunA recently unveiled advances to the company’s proprietary neural cell platform for the production of exosome manufacturing. Today, ArunA’s manufacturing process positions the company to produce AB126 exosomes at a scale to meet early clinical demand. The company has plans to expand this initiative beyond stroke for preclinical studies in epilepsy, traumatic brain and spinal cord injuries later this year.
The Latest on: Stroke treatment
via Google News
The Latest on: Stroke treatment
- NICO.LAB Ready to Revolutionize U.S. Stroke Care Following FDA Clearanceon November 26, 2020 at 10:13 am
This week the FDA approved a 510k application (FDA K200873) for StrokeViewer LVO, an artificial intelligence algorithm for fast triaging of stroke patients. StrokeViewer LVO detects image ...
- High Systolic BP After EVT for Stroke Tied to Poor Outcomeson November 26, 2020 at 9:40 am
Greater disability and increased risk of symptomatic intracranial hemorrhage are more likely if a patient has high blood pressure during the first 6 hours after undergoing endovascular therapy.
- Doctor reminds stroke patients to go to hospital amid COVID-19 pandemicon November 26, 2020 at 5:36 am
A doctor reminded patients experiencing stroke to go to the hospital and seek medical treatment amid the COVID-19 pandemic. According to Cedric Castillo’s report on “24 Oras” on Thursday, Dr. Maria ...
- Medical Cannabis Advocate And Innovator Rick Simpson Opens Up About Stroke Recoveryon November 25, 2020 at 1:07 pm
Lauded cannabis innovator Rick Simpson and his family are asking for assistance as he recovers from a stroke. A prominent cannabis activist and medical marijuana pioneer finds himself in an hour of ...
- Stroke deaths up in Germany during virus shutdown, study showson November 25, 2020 at 7:49 am
More people than usual died from strokes during Germany's spring coronavirus lockdown, a study by health insurer AOK showed Wednesday, blaming fears about going to hospital.
- While vacationing on an isolated island, she had a strokeon November 24, 2020 at 3:02 pm
Doctors said they weren't equipped to treat stroke patients. So Dan arranged for an air ambulance to take her to Florida. In the air, Kim held her mother-in-law's hand. "They were sure I was going to ...
- Revealed: Where you can get the best stroke treatment in Australiaon November 24, 2020 at 8:42 am
Australia’s best stroke treatment isn’t to be found at an illustrious city hospital but in the heart of the country at Wagga Wagga Base Hospital.
- Treatment of mental health issues neglected during stroke recoveryon November 23, 2020 at 10:21 pm
The health system is failing to recognize the importance of treating mental health issues in stroke recovery. Stroke attacks the brain, the human control center determining how we move, think, feel ...
- Removing the Ishemic; Stroke Treatment Device Recalled - What You Need To Knowon November 20, 2020 at 1:16 pm
When this happens, parts of the device can be left inside the patient’s blood vessel. This can cause serious injuries, including additional blockage of the vessel, disability, and death. Accordingly, ...
- Emergency treatment for devastating stroke to be tested in Memphison November 19, 2020 at 11:39 am
The University of Tennessee Health Science Center's Stroke Team is joining researchers from more than 100 hospitals worldwide to conduct a National Institutes of Health (NIH)-funded research study ...
via Bing News